63
Participants
Start Date
August 31, 2012
Primary Completion Date
June 12, 2016
Study Completion Date
June 12, 2016
Capecitabine and aflibercept
"Capecitabine given on days 1-14 and off days 15-21. Dose: Phase 1 cohort 1 850mg/m2 Phase 1 cohort 2 1000mg/m2, Phase 2 RPTD.~Aflibercept will be held constant at 6 mg/kg, given intravenously every 3 weeks.~Both agents will be administered on a 21-day cycle."
Virginia Oncology Associates, Norfolk
Duke Cancer Center, Duke University Medical Center, Durham
Collaborators (1)
Sanofi
INDUSTRY
John Strickler, M.D.
OTHER